VLIARO Trademark

Trademark Overview


On Wednesday, June 14, 2017, a trademark application was filed for VLIARO with the United States Patent and Trademark Office. The USPTO has given the VLIARO trademark a serial number of 87488854. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 16, 2020. This trademark is owned by Novartis AG. The VLIARO trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the preve...
vliaro

General Information


Serial Number87488854
Word MarkVLIARO
Filing DateWednesday, June 14, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 16, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 15, 2017

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 21, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel 4002
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Monday, November 16, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 16, 2020ABANDONMENT - NO USE STATEMENT FILED
Thursday, April 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 8, 2020EXTENSION 5 GRANTED
Saturday, April 4, 2020EXTENSION 5 FILED
Wednesday, April 8, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Saturday, April 4, 2020TEAS EXTENSION RECEIVED
Tuesday, October 8, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, October 6, 2019EXTENSION 4 GRANTED
Sunday, October 6, 2019EXTENSION 4 FILED
Sunday, October 6, 2019TEAS EXTENSION RECEIVED
Wednesday, April 10, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 8, 2019EXTENSION 3 GRANTED
Monday, April 8, 2019EXTENSION 3 FILED
Monday, April 8, 2019TEAS EXTENSION RECEIVED
Tuesday, October 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, October 7, 2018EXTENSION 2 GRANTED
Sunday, October 7, 2018EXTENSION 2 FILED
Sunday, October 7, 2018TEAS EXTENSION RECEIVED
Wednesday, April 11, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 9, 2018EXTENSION 1 GRANTED
Monday, April 9, 2018EXTENSION 1 FILED
Monday, April 9, 2018TEAS EXTENSION RECEIVED
Tuesday, October 10, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 15, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 15, 2017PUBLISHED FOR OPPOSITION
Wednesday, July 26, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 3, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 3, 2017ASSIGNED TO EXAMINER
Wednesday, June 21, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 17, 2017NEW APPLICATION ENTERED IN TRAM